Newborn Screening Laboratory definition

Newborn Screening Laboratory means a laboratory operated by the Department or a laboratory certified by the Department to conduct the tests and carry out the follow-up required by these procedures.
Sample 1Sample 2Sample 3
Newborn Screening Laboratory means an entity contracted with the Department under A.R.S. § 36-694(C) to per- form the newborn screening test.
Sample 1Sample 2
Newborn Screening Laboratory means a laboratory operated by the
Sample 1

Examples of Newborn Screening Laboratory in a sentence

  • See Appendix 4 for an explanation of why information pertaining to follow-up of abnormal NBS results is exempt from HIPAA.NBS Result Request Policy‌The homebirth attendant who submitted the NBS specimen will receive the Newborn Screening Laboratory Report and the Physician Forward Copy to send to the newborn’s primary care provider.The NBS Program does not give NBS results over the telephone.

  • It is then sent to the National Newborn Screening Laboratory in Queen Elizabeth University Hospital for analysis.

  • If no test results are received within fifteen (15) days after the date of collection, the hospital shall contact the Newborn Screening Laboratory to verify that a specimen had been received.

  • Newborn Screening Laboratory results have important implications for all children born in the State of Michigan.

  • Authorized providers can access newborn screening results on-line through the State Electronic Notification Surveillance System (SendSS) or DPH Newborn Screening Laboratory web portal (eReports): https://services.georgia.gov/dph/eReports/.

  • The function of the Newborn Screening Laboratory is to ensure the health and well-being of all infants born in the State of Michigan as mandated by Michigan law and accepted medical practice.

  • It is within this Court’s discretion to consider additional documents filed with a 12(b)(6) Motion.

  • The new requirements apply to all hospitals and birthing providers throughout the state.Under the rule revision, each hospital or health care provider attending a birth outside of a hospital is required to collect and transport specimens to the Newborn Screening Laboratory within specified timeframes.

  • Any laboratory performing newborn screening tests shall be certified by the Department as a Newborn Screening Laboratory.

  • N.E. 150th Street • Shoreline, WA 98155-9701 www.doh.wa.gov/nbs • Phone (206) 418-5410 • Toll Free 1-866-660-9050 • Fax (206) 418-5415 DATE TO: NAMESTREET ADDRESS CITY, STATE ZIP CODE FROM: Lain Knowles, Director Newborn Screening RE: Request to Destroy Residual Newborn Screening Specimen This information is provided in response to your request for destruction of residual dried blood specimens currently stored at the Washington State Newborn Screening Laboratory.


More Definitions of Newborn Screening Laboratory

Newborn Screening Laboratory means a laboratory with which the Department contracts to conduct testing of the newborn screening specimens.
Sample 1

Related to Newborn Screening Laboratory

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Approved laboratory means a laboratory that is listed in the national conference of interstate milk shipments list of sanitation compliance and enforcement ratings distributed by the United States food and drug administration and as approved by the director.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Dental laboratory means a person, firm or corporation

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Laboratory or “LANL” means the geographical location of Los Alamos National Laboratory, a federally funded research and development center owned by the DOE / NNSA.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Non-Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.